{
    "organizations": [],
    "uuid": "786bde6f92f7bc583c6b08f0529932d4b2814f05",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sms-pharmaceuticals-gets-eir-from/brief-sms-pharmaceuticals-gets-eir-from-u-s-fda-for-manufacturing-facility-in-hyderabad-idUSFWN1PH074",
    "ord_in_thread": 0,
    "title": "BRIEF-SMS Pharmaceuticals Gets EIR From U.S. FDA for Manufacturing Facility in Hyderabad",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 22 (Reuters) - Sms Pharmaceuticals Ltd:\n* GETS ESTABLISHMENT INSPECTION REPORT(EIR) FROM US FDA * SAYS THERE WERE NO FORM 483 OBSERVATIONS DURING OF FACILITY IN HYDERABAD Source text - bit.ly/2BjYi32 Further company coverage:\n ",
    "published": "2018-01-22T17:05:00.000+02:00",
    "crawled": "2018-01-23T17:50:03.005+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "sm",
        "pharmaceutical",
        "ltd",
        "get",
        "establishment",
        "inspection",
        "report",
        "eir",
        "u",
        "fda",
        "say",
        "form",
        "observation",
        "facility",
        "hyderabad",
        "source",
        "text",
        "company",
        "coverage"
    ]
}